Molecular characterization of the peripheral airway field of cancerization in lung adenocarcinoma

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Tsay, Jun Chieh J ^a   Li, Zhiguo ^b   Yie, Ting An ^a   Wu, Feng ^a   Segal, Leopoldo ^a   Greenberg, Alissa K ^a   Leibert, Eric ^a   Weiden, Michael D ^a   Pass, Harvey ^a   Munger, John ^a   Statnikov, Alexander ^a,b   Tchou Wong, Kam Meng ^a   Rom, William N ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; MESSENGER RNA;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FIELD OF CANCERIZATION; GENE EXPRESSION PROFILING; GENE INTERACTION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM CELL; MALE; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; SMOKING; UPREGULATION; ADENOCARCINOMA; CELL TRANSFORMATION; DNA MICROARRAY; EPITHELIUM CELL; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; RESPIRATORY SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; AGED; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RESPIRATORY SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMOKING;

EID: 84923382382     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118132     Document Type: Article

References (66)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29. doi: 10.3322/caac.20138 PMID: 22237781
2. The International Early Lung Cancer Action Program Investigators (2006) Survival of Patients with Stage I Lung Cancer Detected on CT Screening. New England Journal of Medicine 355: 1763-1771. PMID: 17065637
3. Steiling K, Kadar AY, Bergerat A, Flanigon J, Sridhar S, et al. (2009) Comparison of proteomic and transcriptomic profiles in the bronchial airway epithelium of current and never smokers. PLoS One 4: e5043. doi: 10.1371/journal.pone.0005043 PMID: 19357784
4. Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6: 963-968. PMID: 13094644
5. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, et al. (1998) Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A 95: 11891-11896. PMID: 9751761
6. Franklin WA, Gazdar AF, Haney J, Wistuba II, La Rosa FG, et al. (1997) Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest 100: 2133-2137. PMID: 9329980
7. Guo M, House MG, Hooker C, Han Y, Heath E, et al. (2004) Promoter hypermethylation of resected bronchial margins: a field defect of changes? Clin Cancer Res 10: 5131-5136. PMID: 15297416
8. Nelson MA, Wymer J, Clements N Jr (1996) Detection of K-ras gene mutations in non-neoplastic lung tissue and lung cancers. Cancer Lett 103: 115-121. PMID: 8616804
9. Powell CA, Klares S, O'Connor G, Brody JS (1999) Loss of heterozygosity in epithelial cells obtained by bronchial brushing: clinical utility in lung cancer. Clin Cancer Res 5: 2025-2034. PMID: 10473082
10. Tang X, Shigematsu H, Bekele BN, Roth JA, Minna JD, et al. (2005) EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. Cancer Res 65: 7568-7572. PMID: 16140919
11. Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, et al. (2000) High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 60: 1949-1960. PMID: 10766185
12. Peng Y, Dai Y, Hitchcock C, Yang X, Kassis ES, et al. (2013) Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer. Proceedings of the National Academy of Sciences.
13. Perdomo C, Spira A, Schembri F (2011) MiRNAs as regulators of the response to inhaled environmental toxins and airway carcinogenesis. Mutat Res 717: 32-37. doi: 10.1016/j.mrfmmm.2011.04.005 PMID: 21549133
14. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257-2261. PMID: 16461460
15. Boeri M, Verri C, Conte D, Roz L, Modena P, et al. (2011) MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 108: 3713-3718. doi: 10.1073/pnas.1100048108 PMID: 21300873
16. Iorio MV, Croce CM (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4: 143-159. doi: 10.1002/emmm.201100209 PMID: 22351564
17. Spira A, Beane JE, Shah V, Steiling K, Liu G, et al. (2007) Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 13: 361-366. PMID: 17334370
18. Harvey BG, Heguy A, Leopold PL, Carolan BJ, Ferris B, et al. (2007) Modification of gene expression of the small airway epithelium in response to cigarette smoking. J Mol Med (Berl) 85: 39-53. PMID: 17115125
19. Heguy A, O'Connor, Luettich K, Worgall S, Cieciuch A, et al. (2006) Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking. J Mol Med (Berl) 84: 318-328. PMID: 16520944
20. Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, et al. (2012) DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Research 40: W498-W504. doi: 10.1093/nar/gks494 PMID: 22649059
21. Vosa U, Vooder T, Kolde R, Fischer K, Valk K, et al. (2011) Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer. Genes Chromosomes Cancer 50: 812-822. doi: 10.1002/gcc.20902 PMID: 21748820
22. Borges M, Linnoila RI, van de Velde HJ, Chen H, Nelkin BD, et al. (1997) An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature 386: 852-855. PMID: 9126746
23. Linnoila RI, Zhao B, DeMayo JL, Nelkin BD, Baylin SB, et al. (2000) Constitutive Achaete-Scute Homologue-1 Promotes Airway Dysplasia and Lung Neuroendocrine Tumors in Transgenic Mice. Cancer Res 60: 4005-4009. PMID: 10945598
24. Li Y, Linnoila RI (2012) Multidirectional differentiation of Achaete-Scute homologue-1-defined progenitors in lung development and injury repair. Am J Respir Cell Mol Biol 47: 768-775. doi: 10.1165/rcmb.2012-0027OC PMID: 22878413
25. Kapur M, Wang W, Maloney MT, Millan I, Lundin VF, et al. (2012) Calcium tips the balance: a microtubule plus end to lattice binding switch operates in the carboxyl terminus of BPAG1n4. EMBO Rep 13: 1021-1029. doi: 10.1038/embor.2012.140 PMID: 22995871
26. Klein RM, Aplin AE (2009) Rnd3 Regulation of the Actin Cytoskeleton Promotes Melanoma Migration and Invasive Outgrowth in Three Dimensions. Cancer Res 69: 2224-2233. doi: 10.1158/0008-5472.CAN-08-3201 PMID: 19244113
27. Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K, et al. (2010) MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta 411: 846-852. doi: 10.1016/j.cca.2010.02.074 PMID: 20223231
28. Holla VR, Mann JR, Shi Q, DuBois RN (2006) Prostaglandin E2 Regulates the Nuclear Receptor NR4A2 in Colorectal Cancer. Journal of Biological Chemistry 281: 2676-2682. PMID: 16293616
29. Sanjo H, Kawai T, Akira S (1998) DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis. J Biol Chem 273: 29066-29071. PMID: 9786912
30. Gkirtzimanaki K, Gkouskou KK, Oleksiewicz U, Nikolaidis G, Vyrla D, et al. (2013) TPL2 kinase is a suppressor of lung carcinogenesis. Proc Natl Acad Sci U S A 110: E1470-1479. doi: 10.1073/pnas.1215938110 PMID: 23533274
31. Wang Y, Li Z, Xu P, Huang L, Tong J, et al. (2011) Angiomotin-like2 gene (amotl2) is required for migration and proliferation of endothelial cells during angiogenesis. J Biol Chem 286: 41095-41104. doi: 10.1074/jbc.M111.296806 PMID: 21937427
32. Lee S, Lim HJ, Park JH, Lee KS, Jang Y, et al. (2007) Berberine-induced LDLR up-regulation involves JNK pathway. Biochem Biophys Res Commun 362: 853-857. PMID: 17767919
33. Wang L, Shi M, Hou S, Ding B, Liu L, et al. (2012) MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1. FEBS Lett 586: 1312-1317. doi: 10.1016/j.febslet.2012.03.035 PMID: 22465663
34. Liu B, Wu X, Wang C, Liu Y, Zhou Q, et al. (2012) MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim Biophys Acta 1822: 1692-1704. doi: 10.1016/j.bbadis.2012.07.019 PMID: 22885155
35. Ueki K, Yballe CM, Brachmann SM, Vicent D, Watt JM, et al. (2002) Increased insulin sensitivity in mice lacking p85β subunit of phosphoinositide 3-kinase. Proceedings of the National Academy of Sciences 99: 419-424. PMID: 11752399
36. Shen J, Wang A, Wang Q, Gurvich I, Siegel AB, et al. (2013) Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a potential biomarker. Cancer Epidemiol Biomarkers Prev 22: 2364-2373. doi: 10.1158/1055-9965.EPI-13-0237 PMID: 24127413
37. Gaedcke J, Grade M, Camps J, Sokilde R, Kaczkowski B, et al. (2012) The rectal cancer microRNAome - microRNA expression in rectal cancer and matched normal mucosa. Clin Cancer Res 18: 4919-4930. PMID: 22850566
38. Fukui S, Sekiguchi M, Miyata K, Ohdaira H, Yoshia K (2013) MicroRNA as a Modulator of Cell Proliferation and Senescence: Role in Lung Cancer Cells. In: Hayat MA, editor. Tumor Dormancy, Quiescence, and Senescence, Volume 1: Aging, Cancer, and Noncancer Pathologies: Springer. pp. 270-279.
39. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838. PMID: 15944708
40. Perdomo C, Campbell JD, Gerrein J, Tellez CS, Garrison CB, et al. (2013) MicroRNA 4423 is a primate-specific regulator of airway epithelial cell differentiation and lung carcinogenesis. Proc Natl Acad Sci U S A 110: 18946-18951. doi: 10.1073/pnas.1220319110 PMID: 24158479
41. Mascaux C, Laes JF, Anthoine G, Haller A, Ninane V, et al. (2009) Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur Respir J 33: 352-359. doi: 10.1183/09031936.00084108 PMID: 19010987
42. Gomperts BN, Walser TC, Spira A, Dubinett SM (2013) Enriching the molecular definition of the airway "field of cancerization:" establishing new paradigms for the patient at risk for lung cancer. Cancer Prev Res (Phila) 6: 4-7.
43. Meloche S, Pouyssegur J (2007) The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26: 3227-3239. PMID: 17496918
44. Chen Y, Nowak I, Huang J, Keng PC, Sun H, et al. (2014) Erk/MAP Kinase Signaling Pathway and Neuroendocrine Differentiation of Non-Small-Cell Lung Cancer. J Thorac Oncol 9: 50-58. doi: 10.1097/JTO.0000000000000034 PMID: 24346093
45. Vicent S, Lopez-Picazo JM, Toledo G, Lozano MD, Torre W, et al. (2004) ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. Br J Cancer 90: 1047-1052. PMID: 14997206
46. Grant JL, Fishbein MC, Hong LS, Krysan K, Minna JD, et al. (2013) A novel molecular pathway for Snail-dependent, SPARC-mediated invasion in non-small cell lung cancer pathogenesis. Cancer Prev Res (Phila).
47. Khatlani TS, Wislez M, Sun M, Srinivas H, Iwanaga K, et al. (2007) c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells. Oncogene 26: 2658-2666. PMID: 17057737
48. Greenberg AK, Basu S, Hu J, Yie TA, Tchou-Wong KM, et al. (2002) Selective p38 activation in human non-small cell lung cancer. Am J Respir Cell Mol Biol 26: 558-564. PMID: 11970907
49. Kao DD, Oldebeken SR, Rai A, Lubos E, Leopold JA, et al. (2013) Tumor necrosis factor-alpha-mediated suppression of dual-specificity phosphatase 4: crosstalk between NFkappaB and MAPK regulates endothelial cell survival. Mol Cell Biochem 382: 153-162. doi: 10.1007/s11010-013-1730-7 PMID: 23812841
50. Pirola L, Bonnafous S, Johnston AM, Chaussade C, Portis F, et al. (2003) Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6 muscle cells. J Biol Chem 278: 15641-15651. PMID: 12594228
51. Kadara H, Shen L, Fujimoto J, Saintigny P, Chow CW, et al. (2013) Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung cancer patients after definitive surgery by expression profiling. Cancer Prev Res (Phila) 6: 8-17.
52. Kadara H, Fujimoto J, Yoo SY, Maki Y, Gower AC, et al. (2014) Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer. J Natl Cancer Inst 106: dju004. doi: 10.1093/jnci/dju004 PMID: 24563515
53. Gustafson AM, Soldi R, Anderlind C, Scholand MB, Qian J, et al. (2010) Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci Transl Med 2: 26ra25. doi: 10.1126/scitranslmed.3000251 PMID: 20375364
54. Tsay JJ, Tchou-Wong KM, Greenberg AK, Pass H, Rom WN (2013) Aryl hydrocarbon receptor and lung cancer. Anticancer Res 33: 1247-1256. PMID: 23564762
55. Hirota T, Date Y, Nishibatake Y, Takane H, Fukuoka Y, et al. (2012) Dihydropyrimidine dehydrogenase (DPD) expression is negatively regulated by certain microRNAs in human lung tissues. Lung Cancer 77: 16-23. doi: 10.1016/j.lungcan.2011.12.018 PMID: 22306127
56. Kang YJ, Jo JO, Ock MS, Chang HK, Baek KW, et al. (2014) Human ERV3-1 env protein expression in various human tissues and tumours. J Clin Pathol 67: 86-90. doi: 10.1136/jclinpath-2013-201841 PMID: 24043713
57. Gueddari N, Favre G, Hachem H, Marek E, Le Gaillard F, et al. (1993) Evidence for up-regulated low density lipoprotein receptor in human lung adenocarcinoma cell line A549. Biochimie 75: 811-819. PMID: 8274533
58. Prudkin L, Behrens C, Liu DD, Zhou X, Ozburn NC, et al. (2008) Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer. Clin Cancer Res 14: 41-47. doi: 10.1158/1078-0432.CCR-07-1252 PMID: 18172250
59. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198. PMID: 16530703
60. Dang X, Ma A, Yang L, Hu H, Zhu B, et al. (2012) MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells. Cancer Genet 205: 113-123. doi: 10.1016/j.cancergen.2012.01.002 PMID: 22469510
61. Song Q, Xu Y, Yang C, Chen Z, Jia C, et al. (2014) miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM. Cancer Res 74: 3031-3042. doi: 10.1158/0008-5472.CAN-13-2193 PMID: 24710410
62. Lin C, Song L, Liu A, Gong H, Lin X, et al. (2014) Overexpression of AKIP1 promotes angiogenesis and lymphangiogenesis in human esophageal squamous cell carcinoma. Oncogene.
63. Jang JS, Jeon HS, Sun Z, Aubry MC, Tang H, et al. (2012) Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers. Clin Cancer Res 18: 3658-3667. doi: 10.1158/1078-0432.CCR-11-2857 PMID: 22573352
64. Hua S, Xiaotao X, Renhua G, Yongmei Y, Lianke L, et al. (2012) Reduced miR-31 and let-7 maintain the balance between differentiation and quiescence in lung cancer stem-like side population cells. Biomed Pharmacother 66: 89-97. doi: 10.1016/j.biopha.2011.09.013 PMID: 22301433
65. Kosari F, Ida CM, Aubry MC, Yang L, Kovtun IV, et al. (2014) ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation. Oncogene 33: 3776-3783. doi: 10.1038/onc.2013.359 PMID: 24037524
66. Staudt MR, Buro-Auriemma LJ, Walters MS, Salit J, Vincent T, et al. (2014) Airway Basal stem/progenitor cells have diminished capacity to regenerate airway epithelium in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 190: 955-958. doi: 10.1164/rccm.201406-1167LE PMID: 25317467